Biomerieux 69 Marcy (BMXMF) 104.6955 $BMXMF
Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2014: Supplier Shares and Country Forecasts
M2 - Mon Sep 08, 8:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wcgzf7/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2014: Supplier Shares and Country Forecasts" report to their offering. This new 318-page report from contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 2014 Strategies for the Global Drugs of Abuse Testing Market is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay. The report provides test volume and sales forecasts by country and market segment for the following assays: - Amphetamines - Antidepressants - Barbiturates - Benzodiazepines - Cannabinoids/Marijuana - Cocaine - LSD - Methadone - Methaqualone - Opiates - Phencyclidine (PCP) - Propoxphene Key Topics Covered: A. Major Drugs of Abuse B. Instrumentation Review C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Distribution Strategies for Decentralized Testing Markets E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Companies Mentioned - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/wc...e_horizons
Future Horizons and Growth Strategies in the European Blood Banking Market 2014
M2 - Fri Sep 05, 3:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8fc9mp/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the European Blood Banking Market 2014: Supplier Shares and Country Forecasts" report to their offering. "2014 Opportunities in the European Blood Banking Market" is a new five-country strategic analysis prepared by the author in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview VI. France A. Executive Summary VII. Germany A. Executive Summary VIII. Italy A. Executive Summary IX. Spain A. Executive Summary X. U.K. A. Executive Summary XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/8f...e_horizons
US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies
M2 - Mon Jul 14, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4q5qg/india_genomics) has announced the addition of the "India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies" report to their offering. The advent of the latest inventions and technologies in accurate detection and quicker screening, and the prolific growth in genetic testing have driven the revenues of the Indian molecular diagnostics market in recent years. The increase in the number of patients stricken with infectious diseases have propelled the revenue growth in FY'2013, which has increased 14.3% in FY'2012. The market has transformed from being a labor intensive to the inclusion of latest technologies. Majority of the reagents sales have historically been attributed to the diagnosis of infectious diseases such as tuberculosis, gonorrhea, Chlamydia and influenza virus, as well as the identification and predisposition to several conditions such as cancer and cystic fibrosis. The molecular diagnostics reagents market in India is segmented on the basis of application which includes virology tests, cancer detection, tuberculosis testing, blood screening, HPV testing and others. Molecular diagnosis helps in providing critical information that the healthcare providers and patients need in order to make the right decisions. Molecular diagnostics help in detecting and measuring the presence of genetic material which are associated with a specific health condition. Key Topics Covered: 1. India Genomics and Molecular Diagnostics Market Introduction 2. Government Regulations in Diagnostics Market in India 3. India Molecular Diagnostics Industry - Key Drivers 4. India Molecular Diagnostics Market Size, FY'2008-FY'2013 5. India Molecular Diagnostics Market Segmentation, FY'2008-FY'2013 6. India Molecular Diagnostics Market Trends and Developments 7. Market Share of Major Players in India Molecular Diagnostics Market, FY'2013 8. Molecular Diagnostics Products of Major Players 9. Company Profiles of Major Players in India Molecular Diagnostics Market 10. India Genomics and Molecular Diagnostics Market Future Outlook and Projections, FY'2014-FY'2018 11. Macro-Economic Factors 12. Appendix Companies Mentioned - Abbott Laboratories - BioMerieux - Lab India Healthcare - Qiagen - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/b4...a_genomics
Concise Analysis of the International and Chinese Diagnostic Reagent Industry
M2 - Tue Mar 25, 6:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ch5ghd/global_and) has announced the addition of the "Concise Analysis of the International and Chinese Diagnostic Reagent Industry" report to their offering. The 'Concise Analysis of the International and Chinese Diagnostic Reagent Industry' is a professional and in-depth market research report on the global diagnostic reagent industry with a focus on the Chinese situation. The report first provides basic information on the diagnostic reagent industry, covering definitions, development overview, market share, classification and market demand trends. Diagnostics analysis is provided for both the international and Chinese domestic situations including sales revenue distribution, manufacturers and their market share, downstream industry demand and import/export analysis. Analysis for biochemical, immune, molecular and InVivo diagnostics sectors is carried out. A key feature of the report is its focus on 37 key industry players providing company information, diagnostic products, contact details and 2009-2017 Company Diagnostic Products Sales Revenue and Market Share. Upstream and downstream industry relationship and influence, as well as periodical regional and seasonal characteristics are discussed. Finally the feasibility of new investment projects report are investigates and overall research conclusions offered. With 295 tables and figures the report provides key statistics on the state of the diagnostic reagent industry and is a valuable source of guidance and direction for companies and individuals operating in the market. Key Topics Covered: Chapter One Diagnostic Reagent Overview Chapter Two InVitro Diagnostics Analysis Chapter Three Biochemical Diagnostics Analysis Chapter Four Immune Diagnostics Analysis Chapter Five Molecular Diagnostics Analysis Chapter Six InVivo Diagnostics Analysis Chapter Seven Global Diagnostic Agent Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis and Influence Chapter Nine InVitro Diagnostics Industry SWOT Analysis and New Project Investment Feasibility Analysis Chapter Ten InVitro Diagnostics Industry Research Conclusion Companies Mentioned: - AMRESCO - Abbott - Abcam - Accurex - Anand Brothers - AusBio - BD - BIOMERIEUX - Beckman Coulter - Beijing Jiuqiang - Beijing Wantai - Bejing Kinghawk - Bio-Rad - Biokit - Biosino - DIRUI - Daan Gene - Euroimmun - FosunPharma - GE - InTec - Johnson & Johnson - KHB - Leadman - Life Technologies - Livzon - MBL - Nantong Union Bio - Prionics - Qiagen - R&D Systems - R-Biopharm - Roche - Rsbio - SIMENS - Snibe - Wondfo For more information visit http://www.researchandmarkets.com/research/ch5ghd/global_and
Global Food Safety Testing Market Outlook 2018: The US Accounts for the Maximum Share of the Global Food Safety Testing Market
M2 - Tue Mar 18, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x5hfqg/global_food) has announced the addition of the "Global Food Safety Testing Market Outlook 2018" report to their offering. In the latest research report Global Food Safety Testing Market Outlook 2018, analysts have studied the global food safety testing market in terms of contaminants and key markets. This research is an outcome of extensive primary & secondary research and thorough analysis of industry trends. For the study, we have conducted telephonic interviews with industry experts, such as several food safety testing labs and food safety testing equipment manufacturers. The report covers detailed analysis of the global food safety testing market, which has been further segmented into contaminants, and other key markets. The food safety testing market of contaminants (pathogen, pesticides, toxins and GMO) for 2018 has been forecasted. The author has found that pathogens occupy a considerable share in global food safety testing market by contaminants, after pesticides. Further, the future share for testing of contaminants by various methods has also been provided. Some of the commonly used methods for food safety testing are PCR, chromatography, ELISA, etc. Among all the methods, PCR is the most preferred food safety testing method for pathogens and GMO worldwide. On a similar note, chromatography dominates food pesticide and toxin testing method worldwide. Further, the author has provided the market forecasts of the global food safety testing market along with forecast for countries such as US, China and Europe till 2018. Besides, the author has also observed various food safety regulations in key countries to provide a complete understanding of the global food safety testing market. The report has further incorporated various drivers like technological advancements transforming food safety testing market, etc., which would fuel the growth of global food safety testing market. The author has also included a detailed competitive landscape which includes the business overview, key financials and recent developments of the major players in the industry. Companies Mentioned: -3M -Agilent Technologies -BioMerieux SA -BioRad -DuPont -Eurofins -Idexx Laboratories -Neogen Corporation -Qiagen -Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x5...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Food Safety Testing Market Analysis - 2013 Edition Features Players such as Agilent, Eurofins and Qiagen
M2 - Tue Mar 11, 11:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmjm8h/global_food) has announced the addition of the "Global Food Safety Testing Market Analysis" report to their offering. According to Global Food Safety Testing Market Analysis, a growing number of participants in the global food market, an increased oversight and monitoring of the manufacturing and supply processes, and the introduction of new automation technologies, all will be instrumental for an enormous growth in the global food testing market. Globalization of food trade, rising consumer awareness about the safety of their food products, increased incidences of food-borne diseases and automation in food testing labs are going to be the major drivers for the food testing market. Among the various segments in food testing, pathogen testing forms a major chunk. In this report, alongside pathogen testing, the authors also cover other important segments such as GMO and pesticide testing. The authors have highlighted key geographical markets such as the United States that is adopting high-end technological food testing programs to minimize risks from contamination. Policy decisions such as Food Modernization Act are being taken up to shift focus towards prevention. On the other hand, Europe, one of the largest importers of food, has been restricting itself with traditional testing technologies. In comparison, developing nations, like India and China, are going through a transformation phase, backed by increased spending from the government. The report analyzes the food safety testing market in these areas in the context of the upcoming technologies and regulatory reforms. According to this study, regulatory amendments and technological developments are indicative that the industry will experience prodigious growth in the coming future. Companies Mentioned: - 3M - Agilent - BioMerieux SA - BioRad - DuPont Qualicon - Eurofins - Idexx Laboratories - Neogen Corp. - Qiagen - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/hm...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market
M2 - Fri Feb 28, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zjkz2c/enzymelinked) has announced the addition of the "Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market" report to their offering. This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousand by the following Product Segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 110 companies including many key and niche players such as: - American Laboratory Products Company - BD Biosciences - BioMerieux SA - Bio-Rad Laboratories, Inc. - EMD Millipore Corp. - Life Technologies Corporation - Ortho-Clinical Diagnostics, Inc. - R&D Systems, Inc. - Thermo Fisher Scientific, Inc. - ZEUS Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Immunochemistry - An Introduction 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 110 (including Divisions/Subsidiaries - 117) - The United States (76) - Canada (3) - Japan (1) - Europe (28) - France (1) - Germany (
- The United Kingdom ( - Spain (1) - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/zj...zymelinked
2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices
M2 - Mon Feb 10, 3:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/cgfkld/2014_analysis_of) has announced the addition of the "2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices" report to their offering. This new 271-page report provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Endocrine Function Tests B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Market Size, Growth and Major Supplier Shares Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies Potential Market Entry Barriers and Risks Competitive Assessments - Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/cg...nalysis_of
2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/fg4rzr/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 800 pages, 240 tables and provides forecasts for 40 blood typing, grouping and infectious disease screening tests by country and market segment, as well as sales and market shares of leading reagent and instrument suppliers. The report is available by region, country and section: Regions: Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA Sections: Assays, Competitors, Instrumentation, Technologies To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious B. Instrumentation Review: Operating Characteristics, C. Major in Vitro Diagnostic Technologies And Their Potential Applications D. Worldwide Market Overview France Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Bio-Rad - BioMerieux - Gen-Probe - Grifols - Immucor - Nanosphere - Ortho-Clinical Diagnostics - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/fg...nalysis_of
2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/nrl9dz/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 1,115 pages, 450 tables and provides forecasts for 100 tests by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and test group: Regions:Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA. Sections: Assays, Competitors, Instrumentation,Technologies Market Segments: Home/Self Testing, Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Point-of-Care Test Groups: Diabetes/Glucose Testing, Drugs of Abuse, POC, Endocrine, Immunoproteins, Lipids, TDM, Tumor Markers/Specialty Chemistry To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Routine Chemistry Tests B. Therapeutic Drug Monitoring (TDM) C. Endocrine Function Tests D. Tumor Markers And Special Chemistry Tests E. Immunoprotein Tests F. Drugs of Abuse G. Instrumentation Review: Operating Characteristics H. Major In Vitro Diagnostic Technologies Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/nr...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Endocrine Function Diagnostics Market to See Considerable Changes in Next 10 Years, States VPG in Its Report Published at MarketPublishers.com
PRWeb - Wed Jan 15, 12:32PM CST
Currently, the diabetes testing represents the biggest market for the endocrine function diagnostics. The world prevalence of diabetes is anticipated to increase from nearly 382 million in 2013 to around 592 million in 2035, spurring considerably the global endocrine function diagnostics market. The main market growth stimulators include, among others, the high prevalence of some other diseases (hypothyroidism, polycystic ovary syndrome and hyperthyroidism, etc.), technological advancements in the endocrine function diagnostics, increasing healthcare IT penetration, steadily improving reimbursement and regulatory frameworks worldwide. North America is the dominant regional market for endocrine function diagnostics. BioMerieux, Beckman Coulter/Danaher, Instrumentation Laboratory, Roche, Kyowa Medex, Fujirebio, Abbott Laboratories, Thermo Fisher and Bio-Rad are among the entrenched players in the world endocrine function diagnostics market.
2014 Opportunities in the US Blood Banking Market
M2 - Tue Sep 10, 10:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3n5fm8/2014) has announced the addition of the "2014 Opportunities in the US Blood Banking Market" report to their offering. 2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. U.S.A. VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/3n5fm8/2014
2014 Opportunities in the Spanish Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jksfrr/2014) has announced the addition of the "2014 Opportunities in the Spanish Blood Banking Market" report to their offering. 2014 Opportunities in the Spanish Blood Banking Market is a new strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Spanish blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Spain; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Spain VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/jksfrr/2014
2014 Opportunities in the Italian Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2xh39t/2014) has announced the addition of the "2014 Opportunities in the Italian Blood Banking Market" report to their offering. 2014 Opportunities in the Italian Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Italian blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Italy; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Italy VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2xh39t/2014
2014 Opportunities in the Japanese Blood Banking Market
M2 - Tue Sep 10, 9:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6pm3km/2014) has announced the addition of the "2014 Opportunities in the Japanese Blood Banking Market" report to their offering. 2014 Opportunities in the Japanese Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Japan VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/6pm3km/2014
2014 Opportunities in the German Blood Banking Market
M2 - Tue Sep 10, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7hrmr8/2014) has announced the addition of the "2014 Opportunities in the German Blood Banking Market" report to their offering. 2014 Opportunities in the German Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the German blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Germany; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Germany VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/7hrmr8/2014
2014 Opportunities in the European Blood Banking Market
M2 - Tue Sep 10, 9:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m72czr/2014) has announced the addition of the "2014 Opportunities in the European Blood Banking Market" report to their offering. 2014 Opportunities in the European Blood Banking Market is a new five-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I.Introduction II. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary III. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts IV. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection V.Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic TechnologiesAnd Their Potential Applications VI. France VII. Germany VIII. Italy IX. Spain X. U.K. XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix For more information visit http://www.researchandmarkets.com/research/m72czr/2014
2014 Opportunities in the French Blood Banking Market
M2 - Tue Sep 10, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rkjf7/2014) has announced the addition of the "2014 Opportunities in the French Blood Banking Market" report to their offering. 2014 Opportunities in the French Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the French blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the France; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2rkjf7/2014
Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2014: Supplier Shares and Country Forecasts
M2 - Mon Sep 08, 8:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wcgzf7/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2014: Supplier Shares and Country Forecasts" report to their offering. This new 318-page report from contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 2014 Strategies for the Global Drugs of Abuse Testing Market is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay. The report provides test volume and sales forecasts by country and market segment for the following assays: - Amphetamines - Antidepressants - Barbiturates - Benzodiazepines - Cannabinoids/Marijuana - Cocaine - LSD - Methadone - Methaqualone - Opiates - Phencyclidine (PCP) - Propoxphene Key Topics Covered: A. Major Drugs of Abuse B. Instrumentation Review C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Distribution Strategies for Decentralized Testing Markets E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Companies Mentioned - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/wc...e_horizons
Future Horizons and Growth Strategies in the European Blood Banking Market 2014
M2 - Fri Sep 05, 3:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8fc9mp/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the European Blood Banking Market 2014: Supplier Shares and Country Forecasts" report to their offering. "2014 Opportunities in the European Blood Banking Market" is a new five-country strategic analysis prepared by the author in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview VI. France A. Executive Summary VII. Germany A. Executive Summary VIII. Italy A. Executive Summary IX. Spain A. Executive Summary X. U.K. A. Executive Summary XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/8f...e_horizons
US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies
M2 - Mon Jul 14, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4q5qg/india_genomics) has announced the addition of the "India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies" report to their offering. The advent of the latest inventions and technologies in accurate detection and quicker screening, and the prolific growth in genetic testing have driven the revenues of the Indian molecular diagnostics market in recent years. The increase in the number of patients stricken with infectious diseases have propelled the revenue growth in FY'2013, which has increased 14.3% in FY'2012. The market has transformed from being a labor intensive to the inclusion of latest technologies. Majority of the reagents sales have historically been attributed to the diagnosis of infectious diseases such as tuberculosis, gonorrhea, Chlamydia and influenza virus, as well as the identification and predisposition to several conditions such as cancer and cystic fibrosis. The molecular diagnostics reagents market in India is segmented on the basis of application which includes virology tests, cancer detection, tuberculosis testing, blood screening, HPV testing and others. Molecular diagnosis helps in providing critical information that the healthcare providers and patients need in order to make the right decisions. Molecular diagnostics help in detecting and measuring the presence of genetic material which are associated with a specific health condition. Key Topics Covered: 1. India Genomics and Molecular Diagnostics Market Introduction 2. Government Regulations in Diagnostics Market in India 3. India Molecular Diagnostics Industry - Key Drivers 4. India Molecular Diagnostics Market Size, FY'2008-FY'2013 5. India Molecular Diagnostics Market Segmentation, FY'2008-FY'2013 6. India Molecular Diagnostics Market Trends and Developments 7. Market Share of Major Players in India Molecular Diagnostics Market, FY'2013 8. Molecular Diagnostics Products of Major Players 9. Company Profiles of Major Players in India Molecular Diagnostics Market 10. India Genomics and Molecular Diagnostics Market Future Outlook and Projections, FY'2014-FY'2018 11. Macro-Economic Factors 12. Appendix Companies Mentioned - Abbott Laboratories - BioMerieux - Lab India Healthcare - Qiagen - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/b4...a_genomics
Concise Analysis of the International and Chinese Diagnostic Reagent Industry
M2 - Tue Mar 25, 6:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ch5ghd/global_and) has announced the addition of the "Concise Analysis of the International and Chinese Diagnostic Reagent Industry" report to their offering. The 'Concise Analysis of the International and Chinese Diagnostic Reagent Industry' is a professional and in-depth market research report on the global diagnostic reagent industry with a focus on the Chinese situation. The report first provides basic information on the diagnostic reagent industry, covering definitions, development overview, market share, classification and market demand trends. Diagnostics analysis is provided for both the international and Chinese domestic situations including sales revenue distribution, manufacturers and their market share, downstream industry demand and import/export analysis. Analysis for biochemical, immune, molecular and InVivo diagnostics sectors is carried out. A key feature of the report is its focus on 37 key industry players providing company information, diagnostic products, contact details and 2009-2017 Company Diagnostic Products Sales Revenue and Market Share. Upstream and downstream industry relationship and influence, as well as periodical regional and seasonal characteristics are discussed. Finally the feasibility of new investment projects report are investigates and overall research conclusions offered. With 295 tables and figures the report provides key statistics on the state of the diagnostic reagent industry and is a valuable source of guidance and direction for companies and individuals operating in the market. Key Topics Covered: Chapter One Diagnostic Reagent Overview Chapter Two InVitro Diagnostics Analysis Chapter Three Biochemical Diagnostics Analysis Chapter Four Immune Diagnostics Analysis Chapter Five Molecular Diagnostics Analysis Chapter Six InVivo Diagnostics Analysis Chapter Seven Global Diagnostic Agent Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis and Influence Chapter Nine InVitro Diagnostics Industry SWOT Analysis and New Project Investment Feasibility Analysis Chapter Ten InVitro Diagnostics Industry Research Conclusion Companies Mentioned: - AMRESCO - Abbott - Abcam - Accurex - Anand Brothers - AusBio - BD - BIOMERIEUX - Beckman Coulter - Beijing Jiuqiang - Beijing Wantai - Bejing Kinghawk - Bio-Rad - Biokit - Biosino - DIRUI - Daan Gene - Euroimmun - FosunPharma - GE - InTec - Johnson & Johnson - KHB - Leadman - Life Technologies - Livzon - MBL - Nantong Union Bio - Prionics - Qiagen - R&D Systems - R-Biopharm - Roche - Rsbio - SIMENS - Snibe - Wondfo For more information visit http://www.researchandmarkets.com/research/ch5ghd/global_and
Global Food Safety Testing Market Outlook 2018: The US Accounts for the Maximum Share of the Global Food Safety Testing Market
M2 - Tue Mar 18, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x5hfqg/global_food) has announced the addition of the "Global Food Safety Testing Market Outlook 2018" report to their offering. In the latest research report Global Food Safety Testing Market Outlook 2018, analysts have studied the global food safety testing market in terms of contaminants and key markets. This research is an outcome of extensive primary & secondary research and thorough analysis of industry trends. For the study, we have conducted telephonic interviews with industry experts, such as several food safety testing labs and food safety testing equipment manufacturers. The report covers detailed analysis of the global food safety testing market, which has been further segmented into contaminants, and other key markets. The food safety testing market of contaminants (pathogen, pesticides, toxins and GMO) for 2018 has been forecasted. The author has found that pathogens occupy a considerable share in global food safety testing market by contaminants, after pesticides. Further, the future share for testing of contaminants by various methods has also been provided. Some of the commonly used methods for food safety testing are PCR, chromatography, ELISA, etc. Among all the methods, PCR is the most preferred food safety testing method for pathogens and GMO worldwide. On a similar note, chromatography dominates food pesticide and toxin testing method worldwide. Further, the author has provided the market forecasts of the global food safety testing market along with forecast for countries such as US, China and Europe till 2018. Besides, the author has also observed various food safety regulations in key countries to provide a complete understanding of the global food safety testing market. The report has further incorporated various drivers like technological advancements transforming food safety testing market, etc., which would fuel the growth of global food safety testing market. The author has also included a detailed competitive landscape which includes the business overview, key financials and recent developments of the major players in the industry. Companies Mentioned: -3M -Agilent Technologies -BioMerieux SA -BioRad -DuPont -Eurofins -Idexx Laboratories -Neogen Corporation -Qiagen -Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x5...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Food Safety Testing Market Analysis - 2013 Edition Features Players such as Agilent, Eurofins and Qiagen
M2 - Tue Mar 11, 11:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmjm8h/global_food) has announced the addition of the "Global Food Safety Testing Market Analysis" report to their offering. According to Global Food Safety Testing Market Analysis, a growing number of participants in the global food market, an increased oversight and monitoring of the manufacturing and supply processes, and the introduction of new automation technologies, all will be instrumental for an enormous growth in the global food testing market. Globalization of food trade, rising consumer awareness about the safety of their food products, increased incidences of food-borne diseases and automation in food testing labs are going to be the major drivers for the food testing market. Among the various segments in food testing, pathogen testing forms a major chunk. In this report, alongside pathogen testing, the authors also cover other important segments such as GMO and pesticide testing. The authors have highlighted key geographical markets such as the United States that is adopting high-end technological food testing programs to minimize risks from contamination. Policy decisions such as Food Modernization Act are being taken up to shift focus towards prevention. On the other hand, Europe, one of the largest importers of food, has been restricting itself with traditional testing technologies. In comparison, developing nations, like India and China, are going through a transformation phase, backed by increased spending from the government. The report analyzes the food safety testing market in these areas in the context of the upcoming technologies and regulatory reforms. According to this study, regulatory amendments and technological developments are indicative that the industry will experience prodigious growth in the coming future. Companies Mentioned: - 3M - Agilent - BioMerieux SA - BioRad - DuPont Qualicon - Eurofins - Idexx Laboratories - Neogen Corp. - Qiagen - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/hm...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market
M2 - Fri Feb 28, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zjkz2c/enzymelinked) has announced the addition of the "Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market" report to their offering. This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousand by the following Product Segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 110 companies including many key and niche players such as: - American Laboratory Products Company - BD Biosciences - BioMerieux SA - Bio-Rad Laboratories, Inc. - EMD Millipore Corp. - Life Technologies Corporation - Ortho-Clinical Diagnostics, Inc. - R&D Systems, Inc. - Thermo Fisher Scientific, Inc. - ZEUS Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Immunochemistry - An Introduction 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 110 (including Divisions/Subsidiaries - 117) - The United States (76) - Canada (3) - Japan (1) - Europe (28) - France (1) - Germany (
- The United Kingdom ( - Spain (1) - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/zj...zymelinked 2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices
M2 - Mon Feb 10, 3:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/cgfkld/2014_analysis_of) has announced the addition of the "2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices" report to their offering. This new 271-page report provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Endocrine Function Tests B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Market Size, Growth and Major Supplier Shares Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies Potential Market Entry Barriers and Risks Competitive Assessments - Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/cg...nalysis_of
2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/fg4rzr/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 800 pages, 240 tables and provides forecasts for 40 blood typing, grouping and infectious disease screening tests by country and market segment, as well as sales and market shares of leading reagent and instrument suppliers. The report is available by region, country and section: Regions: Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA Sections: Assays, Competitors, Instrumentation, Technologies To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious B. Instrumentation Review: Operating Characteristics, C. Major in Vitro Diagnostic Technologies And Their Potential Applications D. Worldwide Market Overview France Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Bio-Rad - BioMerieux - Gen-Probe - Grifols - Immucor - Nanosphere - Ortho-Clinical Diagnostics - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/fg...nalysis_of
2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/nrl9dz/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 1,115 pages, 450 tables and provides forecasts for 100 tests by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and test group: Regions:Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA. Sections: Assays, Competitors, Instrumentation,Technologies Market Segments: Home/Self Testing, Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Point-of-Care Test Groups: Diabetes/Glucose Testing, Drugs of Abuse, POC, Endocrine, Immunoproteins, Lipids, TDM, Tumor Markers/Specialty Chemistry To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Routine Chemistry Tests B. Therapeutic Drug Monitoring (TDM) C. Endocrine Function Tests D. Tumor Markers And Special Chemistry Tests E. Immunoprotein Tests F. Drugs of Abuse G. Instrumentation Review: Operating Characteristics H. Major In Vitro Diagnostic Technologies Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/nr...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Endocrine Function Diagnostics Market to See Considerable Changes in Next 10 Years, States VPG in Its Report Published at MarketPublishers.com
PRWeb - Wed Jan 15, 12:32PM CST
Currently, the diabetes testing represents the biggest market for the endocrine function diagnostics. The world prevalence of diabetes is anticipated to increase from nearly 382 million in 2013 to around 592 million in 2035, spurring considerably the global endocrine function diagnostics market. The main market growth stimulators include, among others, the high prevalence of some other diseases (hypothyroidism, polycystic ovary syndrome and hyperthyroidism, etc.), technological advancements in the endocrine function diagnostics, increasing healthcare IT penetration, steadily improving reimbursement and regulatory frameworks worldwide. North America is the dominant regional market for endocrine function diagnostics. BioMerieux, Beckman Coulter/Danaher, Instrumentation Laboratory, Roche, Kyowa Medex, Fujirebio, Abbott Laboratories, Thermo Fisher and Bio-Rad are among the entrenched players in the world endocrine function diagnostics market.
2014 Opportunities in the US Blood Banking Market
M2 - Tue Sep 10, 10:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3n5fm8/2014) has announced the addition of the "2014 Opportunities in the US Blood Banking Market" report to their offering. 2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. U.S.A. VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/3n5fm8/2014
2014 Opportunities in the Spanish Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jksfrr/2014) has announced the addition of the "2014 Opportunities in the Spanish Blood Banking Market" report to their offering. 2014 Opportunities in the Spanish Blood Banking Market is a new strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Spanish blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Spain; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Spain VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/jksfrr/2014
2014 Opportunities in the Italian Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2xh39t/2014) has announced the addition of the "2014 Opportunities in the Italian Blood Banking Market" report to their offering. 2014 Opportunities in the Italian Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Italian blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Italy; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Italy VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2xh39t/2014
2014 Opportunities in the Japanese Blood Banking Market
M2 - Tue Sep 10, 9:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6pm3km/2014) has announced the addition of the "2014 Opportunities in the Japanese Blood Banking Market" report to their offering. 2014 Opportunities in the Japanese Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Japan VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/6pm3km/2014
2014 Opportunities in the German Blood Banking Market
M2 - Tue Sep 10, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7hrmr8/2014) has announced the addition of the "2014 Opportunities in the German Blood Banking Market" report to their offering. 2014 Opportunities in the German Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the German blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Germany; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Germany VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/7hrmr8/2014
2014 Opportunities in the European Blood Banking Market
M2 - Tue Sep 10, 9:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m72czr/2014) has announced the addition of the "2014 Opportunities in the European Blood Banking Market" report to their offering. 2014 Opportunities in the European Blood Banking Market is a new five-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I.Introduction II. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary III. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts IV. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection V.Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic TechnologiesAnd Their Potential Applications VI. France VII. Germany VIII. Italy IX. Spain X. U.K. XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix For more information visit http://www.researchandmarkets.com/research/m72czr/2014
2014 Opportunities in the French Blood Banking Market
M2 - Tue Sep 10, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rkjf7/2014) has announced the addition of the "2014 Opportunities in the French Blood Banking Market" report to their offering. 2014 Opportunities in the French Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the French blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the France; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2rkjf7/2014
